Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference
SAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that company management will present at the Guggenheim 6th Annual Biotechnology Conference on Thursday, February 8, 2024, at 11:30 a.m. ET.
Related news for (TVTX)
- Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
- Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
- Travere Therapeutics to Submit sNDA for FILSPARI® (sparsentan) in FSGS
- Travere Therapeutics Provides Corporate Update and 2025 Outlook
- travere therapeutics reports third quarter 2024 financial results